Hydrocodone Industry - Regional Synopsis
Europe industry is anticipated to account for largest revenue share by 2037, propelled by advancements in the healthcare sector in the region.Moreover, the increasing investment in the medical research is estimated to further propel the market growth.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rising cases of arthritis and other diseases, which requires pain killer drugs. According to the data by the Center for Disease Control and Prevention (CDC), about 58.5 million people, which is 23.7% of the total population in the United States, have doctor-diagnosed arthritis. Moreover, the liberty to research with narcotics for medicinal use, in developed countries, is anticipated to propel the hydrocodone market growth.
